Tandem mass spectrometry for the direct assay of lysosomal enzymes in dried blood spots: application to screening newborns for mucopolysaccharidosis IVA.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Clinical Chemistry

• Publication date

  2008-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1373/clinchem.2010.149880PMID 21030685PMCID PMC3442110
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Design and synthesis of substrates for newborn screening of Maroteaux-Lamy and Morquio A syndromes.

  2010cited by this paper
• Tandem mass spectrometry for the direct assay of lysosomal enzymes in dried blood spots: application to screening newborns for mucopolysaccharidosis I.

  2008cited by this paper
• Tandem mass spectrometry for the direct assay of lysosomal enzymes in dried blood spots

  2008cited by this paper
• Expanded newborn screening of inherited metabolic disorders by tandem mass spectrometry: clinical and laboratory aspects.

  2006influential reference
• The first 5years of clinical experience with laronidase enzyme replacement therapy for mucopolysaccharidosis I

  2005cited by this paper
• Tandem mass spectrometric analysis of dried blood spots for screening of mucopolysaccharidosis I in newborns.

  2005influential reference
• Tandem mass spectrometry for the direct assay of enzymes in dried blood spots: application to newborn screening for Krabbe disease.

  2004cited by this paper
• Direct multiplex assay of lysosomal enzymes in dried blood spots for newborn screening.

  2004cited by this paper
• Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns.

  2003cited by this paper
• The Metabolic and Molecular Bases of Inherited Disease

  2001cited by this paper
• Diagnosis of alpha-L-iduronidase deficiency in dried blood spots on filter paper: the possibility of newborn diagnosis.

  2001cited by this paper
• Bone marrow transplantation for globoid cell leukodystrophy, adrenoleukodystrophy, metachromatic leukodystrophy, and Hurler syndrome.

  1999cited by this paper
• N-acetylgalactosamine-6-sulfate sulfatase in human placenta : purification and characteristics

  1992cited by this paper
• N-acetylgalactosamine-6-sulfate sulfatase in human placenta: purification and characteristics.

  1991cited by this paper
• A fluorimetric enzyme assay for the diagnosis of Morquio disease type A (MPS IV A).

  1990cited by this paper
• A sensitive procedure for the diagnosis of N-acetyl-galactosamine-6-sulfate sulfatase deficiency in classical Morquio's disease.

  1978cited by this paper

• Application of tandem mass spectrometry in the screening and diagnosis of mucopolysaccharidoses

  2024cites this paper
• Newborn screening of mucopolysaccharidosis type I

  2022cites this paper
• Measurement of lysosomal enzyme activities: A technical standard of the American College of Medical Genetics and Genomics (ACMG).

  2022cites this paper
• Mucopolysaccharidosis Type I

  2020cites this paper
• Newborn screening of mucopolysaccharidoses: past, present, and future

  2020cites this paper
• Lysosomal sulfatases: a growing family.

  2020cites this paper
• Taiwan National Newborn Screening Program by Tandem Mass Spectrometry for Mucopolysaccharidoses Types I, II, and VI

  2019cites this paper
• Molecular genetics and metabolism, special edition: Diagnosis, diagnosis and prognosis of Mucopolysaccharidosis IVA.

  2018cites this paper
• Rapid and Modular Assembly of Click Substrates To Assay Enzyme Activity in the Newborn Screening of Lysosomal Storage Disorders

  2018cites this paper
• Newborn screening in mucopolysaccharidoses

  2018cites this paper
• Mis-splicing of the GALNS gene resulting from deep intronic mutations as a cause of Morquio a disease

  2018cites this paper
• Newborn Screening for Lysosomal Storage Disorders: Methodologies for Measurement of Enzymatic Activities in Dried Blood Spots

  2018cites this paper
• Clinical presentation and diagnosis of mucopolysaccharidoses.

  2018cites this paper
• Open issues in Mucopolysaccharidosis type I-Hurler

  2017cites this paper
• Glycosaminoglycan levels in dried blood spots of patients with mucopolysaccharidoses and mucolipidoses.

  2017cites this paper
• Newborn screening for mucopolysaccharidoses: a pilot study of measurement of glycosaminoglycans by tandem mass spectrometry

  2017cites this paper
• Bio-Plex immunoassay measuring the quantity of lysosomal N-acetylgalactosamine-6-sulfatase protein in dried blood spots for the screening of mucopolysaccharidosis IVA in newborn: a pilot study

  2017cites this paper
• Newborn Screening for Pompe Disease

  2017cites this paper
• Quantification of the enzyme activities of iduronate-2-sulfatase, N-acetylgalactosamine-6-sulfatase and N-acetylgalactosamine-4-sulfatase using liquid chromatography-tandem mass spectrometry

  2017cites this paper
• Glycosaminoglycans detection methods: Applications of mass spectrometry.

  2017cites this paper
• Pilot study of newborn screening for six lysosomal storage diseases using Tandem Mass Spectrometry

  2016cites this paper
• Mucopolysaccharidosis Type IVA

  2016cites this paper
• Expanded newborn screening by mass spectrometry: New tests, future perspectives.

  2016cites this paper
• Newborn Screening for Lysosomal Storage Disorders

  2016cites this paper
• Easy method for newborn screening of six lysosomal storage disorders using online solid-phase extraction with mass spectrometry / Altı lizozomal depo hastağının yenidoğan taramasında, online katı faz eksraksiyon kullanılarak kütle spektrometresi ile ölçümünde kolay bir metod

  2016cites this paper
• The use of mass spectrometry to analyze dried blood spots.

  2016cites this paper
• Dried blood spots allow targeted screening to diagnose mucopolysaccharidosis and mucolipidosis.

  2015cites this paper
• Optimizing the Molecular Diagnosis of GALNS: Novel Methods to Define and Characterize Morquio—A Syndrome‐Associated Mutations

  2015cites this paper
• Newborn screening for lysosomal storage diseases.

  2015cites this paper
• Neonatal cellular and gene therapies for mucopolysaccharidoses: the earlier the better?

  2015cites this paper
• Newborn screening for lysosomal storage disorders.

  2015cites this paper
• Tandem Mass Spectrometry Has a Larger Analytical Range than Fluorescence Assays of Lysosomal Enzymes: Application to Newborn Screening and Diagnosis of Mucopolysaccharidoses Types II, IVA, and VI.

  2015cites this paper
• Direct assay of iduronate-2-sulfatase for Hunter disease using UPLC-tandem mass spectrometry and fluorogenic substrate.

  2015cites this paper
• Synergistic interaction between the fibroblast growth factor and bone morphogenetic protein signaling pathways in lens cells

  2015cites this paper
• Diagnosis of Morquio Syndrome in Dried Blood Spots Based on a New MRM-MS Assay

  2015cites this paper
• Synthetic Approaches to L-Iduronic Acid and L-Idose: Key Building Blocks for the Preparation of Glycosaminoglycan Oligosaccharides.

  2015cites this paper
• Chondroitin 6-Sulfate as a Novel Biomarker for Mucopolysaccharidosis IVA and VII.

  2015cites this paper
• The laboratory diagnosis of mucopolysaccharidosis III (Sanfilippo syndrome): A changing landscape.

  2014cites this paper
• Improved Reagents for Newborn Screening of Mucopolysaccharidosis Types I, II, and VI by Tandem Mass Spectrometry

  2014cites this paper
• A Simple and Rapid Method Based on Liquid Chromatography-Tandem Mass Spectrometry for the Measurement of α-L-Iduronidase Activity in Dried Blood Spots: An Application to Mucopolysaccharidosis I (Hurler) Screening

  2014influential citation
• Impact of enzyme replacement therapy and hematopoietic stem cell therapy on growth in patients with Hunter syndrome

  2014cites this paper
• Development of a fluorometric microtiter plate-based enzyme assay for arylsulfatase B (MPS VI) using dried blood spots

  2014cites this paper
• Application of mass spectrometry in newborn screening: about both small molecular diseases and lysosomal storage diseases.

  2014cites this paper
• Mass spectrometry in clinical chemistry: the case of newborn screening.

  2014cites this paper
• Applications of Dried Blood Spots in Newborn and Metabolic Screening

  2014cites this paper
• A US perspective on newborn screening: a powerful tool for prevention

  2014cites this paper
• Mass spectrometry in clinical chemistry: the case of newborn screening.

  2014cites this paper
• Development of a fluorometric microtiter plate based enzyme assay for MPS IVA (Morquio type A) using dried blood spots

  2014cites this paper
• LC–MS/MS in the routine clinical laboratory: has its time come?

  2014cites this paper
• A pilot newborn screening program for Mucopolysaccharidosis type I in Taiwan

  2013cites this paper
• Molecular characterization of 355 mucopolysaccharidosis patients reveals 104 novel mutations

  2013cites this paper
• Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA.

  2013cites this paper
• High-throughput assay of 9 lysosomal enzymes for newborn screening.

  2013cites this paper
• Newborn screening and diagnosis of mucopolysaccharidoses.

  2013cites this paper
• Identification of infants at risk for developing Fabry, Pompe, or mucopolysaccharidosis-I from newborn blood spots by tandem mass spectrometry.

  2013cites this paper
• An algorithm to predict phenotypic severity in mucopolysaccharidosis type I in the first month of life

  2013cites this paper
• Dried blood spots: analysis and applications.

  2013cites this paper
• Residual α-L-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients.

  2013cites this paper
• Screening of Lysosomal Storage Disorders: Application of the Online Trapping-and-Cleanup Liquid Chromatography/Mass Spectrometry Method for Mucopolysaccharidosis I

  2013cites this paper
• Enzymatic Screening and Diagnosis of Lysosomal Storage Diseases.

  2013cites this paper
• Caracterización clínica, estudios genéticos, y manejo de la Mucopolisacaridosis tipo IV A

  2013cites this paper
• Late Diagnosis of a Patient with Morquio Syndrome

  2013cites this paper
• Biochemical genetics and inborn errors of metabolism

  2013cites this paper
• Mass Spectrometry Compatible Enzymatic Assays: Miniaturisation, Automation and Applications

  2013cites this paper
• Diagnosing mucopolysaccharidosis IVA

  2013cites this paper
• Mucopolysaccharidosis type I (MPS I): Assessment of disease severity, therapeutic options and early diagnosis

  2013influential citation
• Newborn screening for lysosomal storage disorders in hungary.

  2012cites this paper
• Neonatal gene therapy with a gamma retroviral vector in mucopolysaccharidosis VI cats.

  2012cites this paper
• New substrates and enzyme assays for the detection of mucopolysaccharidosis III (Sanfilippo Syndrome) types A, B, C, and D by tandem mass spectrometry.

  2012cites this paper
• Entwicklungen und Trends massenspektrometrischer Applikationen für das Neugeborenenscreening

  2012cites this paper
• Short-incubation mass spectrometry assay for lysosomal storage disorders in newborn and high-risk population screening.

  2012cites this paper
• Capturing phenotypic heterogeneity in MPS I: results of an international consensus procedure

  2012cites this paper
• Lysosomal storage diseases: Diagnostic confirmation and management of presymptomatic individuals

  2011cites this paper
• Use of Tandem Mass Spectrometry for Newborn Screening of 6 Lysosomal Storage Disorders in a Korean Population

  2011cites this paper
• The use of dried blood spot samples in the diagnosis of lysosomal storage disorders--current status and perspectives.

  2011cites this paper
• Simplified newborn screening protocol for lysosomal storage disorders.

  2011cites this paper
• Comparative triplex tandem mass spectrometry assays of lysosomal enzyme activities in dried blood spots using fast liquid chromatography: application to newborn screening of Pompe, Fabry, and Hurler diseases.

  2011cites this paper
• The Use of Dried Blood Spots for Concentration Assessment in Pharmacokinetic Evaluations

  2011cites this paper
• Profiling of acylcarnitines and sterols from dried blood or plasma spot by atmospheric pressure thermal desorption chemical ionization (APTDCI) tandem mass spectrometry.

  2011cites this paper
• Diagnóstico de mucopolissacaridose tipo IVA em amostras de sangue impregnado em papel filtro

  2011cites this paper
• Enzyme replacement therapy and/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure

  2011cites this paper
• Diagnosis of the mucopolysaccharidoses.

  2011cites this paper
• The preparation and storage of dried-blood spot quality control materials for lysosomal storage disease screening tests.

  2011cites this paper
• Functional proteomics: application of mass spectrometry to the study of enzymology in complex mixtures

  2011cites this paper
• Noninvasive diagnosis of mucopolysaccharidosis via depth-resolved optical spectroscopy of the outer ear

  2011cites this paper
• Disease-Specific Non-Reducing End Carbohydrate Biomarkers for Mucopolysaccharidoses

  2011cites this paper
• Rapid, single-step assay for Hunter syndrome in dried blood spots using digital microfluidics.

  2011cites this paper
• Practical and reliable enzyme test for the detection of mucopolysaccharidosis IVA (Morquio Syndrome type A) in dried blood samples.

  2011cites this paper
• Protonation sites and dissociation mechanisms of t-butylcarbamates in tandem mass spectrometric assays for newborn screening.

  2011cites this paper
• LC-MS/MS progress in newborn screening.

  2011cites this paper
• Replacing the Enzyme α-l-Iduronidase at Birth Ameliorates Symptoms in the Brain and Periphery of Dogs with Mucopolysaccharidosis Type I

  2010cites this paper
• Tandem mass spectrometry for the direct assay of lysosomal enzymes in dried blood spots: application to screening newborns for mucopolysaccharidosis II (Hunter Syndrome).

  2010cites this paper
• A powerful couple in the future of clinical biochemistry: in situ analysis of dried blood spots by ambient mass spectrometry.

  2010cites this paper
• Early versus late treatment of spinal cord compression with long-term intrathecal enzyme replacement therapy in canine mucopolysaccharidosis type I.

  2010cites this paper
• A tandem mass spectrometry triplex assay for the detection of Fabry, Pompe, and mucopolysaccharidosis-I (Hurler).

  2010cites this paper
• The National Austrian Newborn Screening Program – Eight years experience with mass spectrometry. Past, present, and future goals

  2010cites this paper
• Prenatal diagnosis of mucopolysaccharidosis VI by enzyme assay in a dried spot of fetal blood: a pioneering case report

  2010cites this paper
• Newborn screening for neuropathic lysosomal storage disorders

  2010cites this paper
• Multiplex lysosomal enzyme activity assay on dried blood spots using tandem mass spectrometry.

  2010cites this paper
• Dermatan sulfate and heparan sulfate as a biomarker for mucopolysaccharidosis I

  2010cites this paper